Tennant Philinsider trades
In SEC Form 4 filings, Tennant Phil is listed as Chief Commercial Officer of Precigen, Inc. (PGEN). In the last 90 days, Tennant Phil sold $593.7K of Precigen, Inc. (PGEN) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PGENPrecigen, Inc. | Chief Commercial Officer | 6 | Aug 25 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-25
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | M | 79,166 | $1.61 | $127,457 | 221,158 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | S | 79,166 | $7.50 | Sale −$593,745 | 141,992 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | M · derivative | 79,166 | $1.61 | $127,457 | 120,834 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | M | 5,208 | not reported | not reported | 144,577 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | F | 2,585 | $7.20 | $18,612 | 141,992 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | M · derivative | 5,208 | $0.00 | $0 | 57,292 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.